PMID- 27648638 OWN - NLM STAT- MEDLINE DCOM- 20170626 LR - 20170817 IS - 1539-2864 (Electronic) IS - 0275-004X (Linking) VI - 36 IP - 12 DP - 2016 Dec TI - LYSOPHOSPHATIDIC ACIDS AND AUTOTAXIN IN RETINAL VEIN OCCLUSION. PG - 2311-2318 AB - PURPOSE: To analyze the levels of lysophosphatidic acids (LPAs) and autotaxin (ATX) in undiluted vitreous of untreated patients with retinal vein occlusion (RVO). METHODS: Sixty-four vitreous samples (40 RVO, 24 controls with idiopathic floaters) were analyzed in this retrospective case series using LC/MS for LPAs 16:0, 18:0, 18:1, 20:4, and ELISA kits or Luminex technology for ATX, angiopoetin-1 (ANG-1), interleukin-6 (IL-6), interleukin-7 (IL-7), interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), pigment epithelium-derived factor (PEDF), and vascular endothelial growth factor (VEGF). LPA and ATX levels were correlated with the visual acuity, central macular thickness (CMT), average retinal thickness (AvT), vitreal cytokine levels and with each other. RESULTS: Levels of every LPA species tested and ATX were significantly increased in the vitreous fluid from all patients with RVO (total LPAs: 968.0 +/- 842.3 nM; ATX: 2.5 +/- 1.02 nM) compared with controls (total LPAs: 225.2 +/- 292.8 nM, P < 0.0001; ATX: 1.9 +/- 1.00 nM, P = 0.005). There were strong positive correlations between the vitreal levels of IL-6, IL-8, MCP-1, VEGF and LPAs. CONCLUSION: Levels of LPAs and ATX were positively correlated with proinflammatory cytokines and VEGF and might thus play an important role in the development of macular edema secondary to RVO. FAU - Dacheva, Ivanka AU - Dacheva I AD - *Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany; daggerRoche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland; double daggerDepartment of General Ophthalmology, Medical University of Lublin, Lublin, Poland; section signMedical Research Centre, Polish Academy of Science, Warsaw, Poland; paragraph signDepartment of Ophthalmology, University of Freiburg, Freiburg, Germany; and **Department of Ophthalmology, University of Southern California, Los Angeles, California. FAU - Ullmer, Christoph AU - Ullmer C FAU - Ceglowska, Karolina AU - Ceglowska K FAU - Nogoceke, Everson AU - Nogoceke E FAU - Hartmann, Guido AU - Hartmann G FAU - Muller, Stephan AU - Muller S FAU - Rejdak, Robert AU - Rejdak R FAU - Nowomiejska, Katarzyna AU - Nowomiejska K FAU - Reich, Michael AU - Reich M FAU - Nobl, Matthias AU - Nobl M FAU - Tandogan, Tamer AU - Tandogan T FAU - Kretz, Florian T A AU - Kretz FT FAU - Auffarth, Gerd U AU - Auffarth GU FAU - Koss, Michael J AU - Koss MJ LA - eng PT - Journal Article PL - United States TA - Retina JT - Retina (Philadelphia, Pa.) JID - 8309919 RN - 0 (Cytokines) RN - 0 (Lysophospholipids) RN - EC 3.1.4.- (Phosphoric Diester Hydrolases) RN - EC 3.1.4.39 (alkylglycerophosphoethanolamine phosphodiesterase) SB - IM MH - Aged MH - Cytokines/metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Humans MH - Lysophospholipids/*metabolism MH - Male MH - Middle Aged MH - Phosphoric Diester Hydrolases/*metabolism MH - Retinal Vein Occlusion/*metabolism MH - Retrospective Studies MH - Vitreous Body/metabolism EDAT- 2016/09/21 06:00 MHDA- 2017/06/27 06:00 CRDT- 2016/09/21 06:00 PHST- 2016/09/21 06:00 [pubmed] PHST- 2017/06/27 06:00 [medline] PHST- 2016/09/21 06:00 [entrez] AID - 10.1097/IAE.0000000000001112 [doi] PST - ppublish SO - Retina. 2016 Dec;36(12):2311-2318. doi: 10.1097/IAE.0000000000001112.